Johnson & Johnson
JNJ · NYSE
9/28/2025 | 6/29/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $23,993,000 | $23,743,000 | $21,893,000 | $22,520,000 |
| % Growth | 1.1% | 8.5% | -2.8% | – |
| Cost of Goods Sold | $7,303,000 | $7,628,000 | $7,357,000 | $7,128,000 |
| Gross Profit | $16,690,000 | $16,115,000 | $14,536,000 | $15,392,000 |
| % Margin | 69.6% | 67.9% | 66.4% | 68.3% |
| R&D Expenses | $3,672,000 | $3,516,000 | $3,225,000 | $5,298,000 |
| G&A Expenses | $5,922,000 | $5,789,000 | $5,012,000 | $6,253,000 |
| SG&A Expenses | $5,922,000 | $5,789,000 | $5,012,000 | $6,253,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,594,000 | $9,305,000 | $8,237,000 | $11,551,000 |
| Operating Income | $7,096,000 | $6,810,000 | $6,299,000 | $3,841,000 |
| % Margin | 29.6% | 28.7% | 28.8% | 17.1% |
| Other Income/Exp. Net | $397,000 | -$319,000 | $7,332,000 | $46,000 |
| Pre-Tax Income | $7,493,000 | $6,491,000 | $13,631,000 | $3,887,000 |
| Tax Expense | $2,341,000 | $954,000 | $2,632,000 | $456,000 |
| Net Income | $5,152,000 | $5,537,000 | $10,999,000 | $3,431,000 |
| % Margin | 21.5% | 23.3% | 50.2% | 15.2% |
| EPS | 2.12 | 2.29 | 4.57 | 1.43 |
| % Growth | -7.4% | -49.9% | 219.6% | – |
| EPS Diluted | 2.12 | 2.29 | 4.54 | 1.41 |
| Weighted Avg Shares Out | 2,428,600 | 2,419,100 | 2,405,625 | 2,406,922 |
| Weighted Avg Shares Out Dil | 2,428,600 | 2,419,100 | 2,423,800 | 2,427,100 |
| Supplemental Information | – | – | – | – |
| Interest Income | $227,000 | $260,000 | $332,000 | $281,000 |
| Interest Expense | $18,000 | $308,000 | $204,000 | $137,000 |
| Depreciation & Amortization | $1,777,000 | $1,943,000 | $1,772,000 | $1,896,000 |
| EBITDA | $9,288,000 | $8,742,000 | $15,607,000 | $5,920,000 |
| % Margin | 38.7% | 36.8% | 71.3% | 26.3% |